When our body fights an infection, the immune system must quickly activate defenses and trigger a beneficial inflammatory ...

A common cold can feel like a small thing until it is not. One day you feel fine, and the next you wake up congested, drained ...

New research suggests this divide begins almost the moment you’re exposed. A study from Yale University finds that the earliest responses from the cells lining your nose (triggered within hours of ...

When a rhinovirus, the most frequent cause of the common cold, infects the lining of our nasal passages, our cells work ...

PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for ...

Who knows why different people have different symptoms with the common cold? Well, a new study used laboratory-grown noses ...

Investigators studied expression of type I interferons, key pathogenic drivers in systemic lupus erythematosus and lupus nephritis.

CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...

Treatment of COVID-19 with interferon beta-1b — even for just a few days, a much shorter period than is commonly used for maintenance in multiple sclerosis (MS), for example — is associated with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The possible FDA approval of a drug targeting the ...